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Copper uptake and subsequent delivery to copper-dependent enzymes are essential for many cellular processes. However, the intracellular levels of this nutrient
must be controlled because of its potential toxicity. The
hCtr1 protein functions in high affinity copper uptake
at the plasma membrane of human cells. Recent studies
have shown that elevated copper stimulates the endocytosis and degradation of the hCtr1 protein, and this
response is likely an important homeostatic mechanism
that prevents the overaccumulation of copper. The domains of hCtr1 involved in copper-stimulated endocytosis and degradation are unknown. In this study we examined the importance of potential copper-binding
sequences in the extracellular domain and a conserved
transmembrane 150MXXXM154 motif for copper-stimulated endocytosis and degradation of hCtr1. The endocytic response of hCtr1 to low copper concentrations
required an amino-terminal methionine cluster
(40MMMMPM45) closest to the transmembrane region.
However, this cluster was not required for the endocytic
response to higher copper levels, suggesting this motif
may function as a high affinity copper-sensing domain.
Moreover, the transmembrane 150MXXXM154 motif was
absolutely required for copper-stimulated endocytosis
and degradation of hCtr1 even under high copper concentrations. Together with previous studies demonstrating a role for these motifs in high affinity copper
transport activity, our findings suggest common biochemical mechanisms regulate both transport and trafficking functions of hCtr1.

Copper is an essential trace element required for several
enzymes with critical roles in metabolism, including cytochrome c oxidase, lysyl oxidase, dopamine B hydroxylase, superoxide dismutase, and ferroxidases (1). The ability of copper
to exist in two redox states, Cu⫹ and Cu2⫹, enables coppercontaining enzymes to catalyze electron transfer reactions.
However, these same redox properties of copper also make it
toxic when present in elevated concentrations within cells.
Excess copper can generate the formation of hydroxyl radicals
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that damage lipids, proteins, and nucleic acids. This paradox of
an essential yet toxic nutrient has resulted in the evolution of
sophisticated homeostatic mechanisms that maintain an essential supply and controlled distribution of copper while preventing its overaccumulation. Menkes disease and Wilson disease
provide genetic evidence of the importance of maintaining copper balance in humans. The Menkes and Wilson disease genes,
ATP7A and ATP7B, respectively, encode two closely related
copper-transporting P-type ATPases that are located in the
trans-Golgi network (2– 4). Excess copper concentrations stimulate the trafficking of the ATP7A protein to the plasma membrane where it effluxes copper (2), whereas ATP7B, which is
mainly expressed in the liver, relocates to post-Golgi vesicles
where the transporter is thought to compartmentalize copper
prior to its excretion (4, 5). The copper-stimulated trafficking of
ATP7A/B proteins is an important post-translational mechanism for regulating copper export, and recent studies indicate
that copper-responsive trafficking also regulates mammalian
copper uptake (6).
Studies in the yeast Saccharomyces cerevisiae identified the
first high affinity copper uptake proteins, yCtr11 and yCtr3 (7,
8). These proteins were the founding members of a widely
conserved family of Ctr proteins identified in fungi, plants,
insects, and mammals. Yeast mutants lacking yCtr1 and yCtr3
show several phenotypes consistent with a copper deficiency
(7–9). Analysis of the human hCtr1 and mouse mCtr1 proteins
in mammalian cells indicates these proteins function as copper
importers (10, 11). The deletion of mCtr1 in mice results in a
severe embryonic lethal phenotype, suggesting that high affinity copper uptake via this protein is critical for normal mammalian development (12, 13). Members of the Ctr family are
integral membrane proteins with three membrane-spanning
helices, and studies on yCtr1 and hCtr1 indicate that these
proteins assemble as multimers (11, 14 –16).
Another conserved feature of the Ctr1 protein family is the
existence of methionine-rich sequences in the extracellular
amino-terminal region (1, 16). These sequences, referred to as
“Mets” motifs, have the consensus MXXMXM, and the hCtr1
protein possesses two such motifs. The similarity of Mets motifs to copper-binding domains of the bacterial copper transporters, CopB and CutE, provided initial indications that these
sequences may bind copper (8). Recent studies of yCtr1 and
hCtr1 proteins have revealed that the Mets motifs are essential
for normal copper uptake when extracellular levels are low,

1
The abbreviations used are: yCtr1 and yCtr3, yeast (Saccharomyces
cerevisiae) Ctr1 and Ctr3, respectively; mCtr1, mouse Ctr1; hCtr1,
human Ctr1; HEK, human embryonic kidney; PBS, phosphate-buffered
saline; HRP, horseradish peroxidase; Wt-hCtr1myc, wild type myctagged hCtr1.
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suggesting that these sequences primarily function to scavenge
copper when the metal is scarce (16). All Ctr1 family members
also possess an MXXXM motif, which is predicted to reside
within the second transmembrane domain and is essential for
copper transport activity of yCtr1 and hCtr1 (16).
The hCtr1 and yCtr1 proteins, like the ATP7A/B copper
exporters, are post-translationally regulated by copper availability. Elevated copper stimulates the rapid endocytosis and
degradation of yCtr1 and hCtr1 (6, 17). This process may function to attenuate copper uptake and prevent overaccumulation
of this potentially toxic metal. However, the domains of Ctr1
proteins involved in sensing copper and stimulating endocytosis are unknown. In this study, we examined the role of the
conserved extracellular Mets motifs, two histidine-rich regions,
and the 150MXXXM154 sequence in regulating the copper-responsive endocytosis and degradation of hCtr1. The Mets motif
closest to the first transmembrane region was required to stimulate endocytosis in response to low micromolar copper levels
but not elevated concentrations. Moreover, mutation of either
methionine of the 150MXXXM154 motif completely abolished
copper-responsive endocytosis and degradation of hCtr1 even
under high copper concentrations. These findings suggest a
model whereby the endocytic response of hCtr1 to copper may
require the protein to be a functional copper transporter.
EXPERIMENTAL PROCEDURES

Plasmids, Cell Lines, and Antibodies—The hCtr1 mutations in this
study were either introduced previously into the hCtr1 cDNA (16) or
generated by PCR mutagenesis and subcloned into the pcDNA3.1(⫹)
mammalian expression plasmid. DNA sequencing was used to verify
each mutation. The human embryonic kidney cell line HEK293 was
cultured in Dulbecco’s modified Eagle’s medium containing 10% fetal
bovine serum under 5% CO2. This basal medium contains ⬃1 M
copper. Cells were transfected with the pcDNA3.1 empty vector or the
same vector harboring the wild type or mutant alleles of hCtr1 using
the LipofectAMINE 2000 reagent (Invitrogen) according to the manufacturer’s instructions. After selection for 10 days with 500 g/ml G418,
the expression of the wild type hCtr1 and each mutant protein was
confirmed by immunofluorescence microscopy and Western blotting
(described below) using the 9E10 monoclonal affinity-purified anti-myc
antibody (Roche Applied Science). In specific experiments, de novo
protein synthesis was inhibited by pretreating cells for 30 min with 100
g/ml cycloheximide (ICN), which was subsequently maintained
throughout copper treatments.
Immunofluorescence Microscopy—Cells were grown overnight on
sterile glass coverslips coated with poly(L-lysine) (Sigma), washed twice
with 1 ml of ice-cold PBS, and then fixed for 10 min at 25 °C using 4%
paraformaldehyde. The cells were then permeabilized with 0.1% Triton
X-100 in PBS for 5 min, blocked for 1 h with 1% bovine serum albumin
and 3% skim milk in PBS, and then probed with the anti-myc antibodies
(10 g/ml) followed by Alexa 488 anti-mouse antibodies (1:1000). For
copper-treated samples, 100 M CuCl2 was added to the medium for 2 h
prior to fixing.
Detection of hCtr1 Protein Levels at the Plasma Membrane and Western Blots—The pool of hCtr1-myc at the plasma membrane was assessed by measuring the levels of anti-myc antibodies bound to the
surface of HEK/hCtr1-myc cells as described previously with minor
modifications (6). HEK/hCtr1-myc cells were cultured for 24 h in poly(Llysine)-coated 6-well trays, washed twice with PBS on ice, and blocked
for 10 min with ice-cold PBS containing 5% skim milk. The cells were
then incubated with the anti-myc antibody (1:500) for 20 min at 4 °C.
After washing the cells five times with 2 ml of ice-cold PBS to remove
unbound antibodies, the cells (with retained antibodies) were lysed by
sonication in lysis buffer (62 mM Tris-Cl (pH 6.8), 2% SDS, 100 mM
dithiothreitol, and protease inhibitor mix (Roche Applied Science)) and
then fractionated by 4 –20% SDS-PAGE. After transferring proteins to
nitrocellulose membranes, the anti-myc antibodies were detected using
anti-mouse antibodies conjugated to horseradish peroxidase (HRP) (1:
5000) using a chemiluminescence detection kit (Roche Applied Science).
Tubulin protein levels were detected on parallel immunoblots using
antitubulin antibodies (1:40,000; Sigma). The detection of total myctagged wild type and mutant hCtr1 proteins was performed as described previously (6).
Assay of hCtr1 Endocytosis—The endocytosis of hCtr1-myc was de-

FIG. 1. Characterization of HEK293 cell lines expressing hCtr1
mutant proteins. A, schematic diagram of the hCtr1 protein and
mutations investigated in this study. Alanine substitutions introduced
into the methionine-rich Mets motifs, M1 and M2 (black circles), and
the histidine-rich sequences, H1 and H2 (black squares), are indicated.
The Met150 and Met154 residues of the conserved MXXXM motif were
replaced by alanine. B, Western blot analysis of HEK293 cells stably
expressing hCtr1 mutant proteins shown in A. Total cell lysates were
immunoblotted with anti-myc antibodies to detect hCtr1 protein or with
antitubulin antibodies as a control for protein loading. The 35-kDa
hCtr1 monomer and 70-kDa multimer are indicated (arrows). Wt, wild
type; mut, mutant.
termined by measuring the uptake of anti-myc antibodies added to the
cultured medium of stably transfected HEK293 cells as previously
described (6). Cells were pregrown in 6-well trays for 24 h in basal
medium and then incubated for 5 min at 37 °C in basal or coppersupplemented medium containing 10 g/ml anti-myc antibodies. Cells
were washed twice with PBS on ice, and surface-bound antibodies were
removed by three washes in ice-cold acidic buffer (100 mM glycine, 20
mM magnesium acetate, 50 mM potassium chloride, pH 2.2). Cells were
harvested by scraping into ice-cold PBS and pelleted by centrifugation
at 1000 ⫻ g. The cell pellets were solubilized in SDS buffer (see above),
and 20 g of lysates containing internalized anti-myc antibodies were
separated using 4 –20% SDS-PAGE, transferred to nitrocellulose membranes, and detected by chemiluminescence using anti-mouse HRP
antibodies.
RESULTS

The human Ctr1 protein contains two Mets motifs, M1
(7MGMSYM12) and M2 (40MMMMPM45), and two histidinerich regions, H1 (3HSHH6) and H2 (22HHH24), in the extracellular amino-terminal region (Fig. 1A). Copper uptake experiments using transfected HEK293 cells and complementation
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FIG. 2. Copper-dependent relocalization of the hCtr1 mutant proteins.
Shown is immunofluorescence microscopy
analysis of HEK293 cells expressing each
hCtr1 mutant protein; the cells were exposed to either basal medium (A, C, E, G,
I, K, M, and O) or medium containing 100
M copper (B, D, F, H, J, L, N, and P) for
2 h. The cells were fixed, permeabilized,
and blocked prior to detection of wild type
(Wt) and mutant (mut) hCtr1 proteins using anti-myc antibodies followed by antimouse Alexa 488 secondary antibodies.
Note the severe reduction of copper-induced relocalization of M150A and
M154A mutant proteins from the plasma
membrane.

studies of the yeast ⌬ctr1⌬ctr3⌬ mutant suggest that the M2
motif, but not the M1, H1, or H2 motifs, is required for high
affinity copper uptake activity under low copper conditions
(16). The same study found that both methionines of the conserved 150MXXXM154 motif are absolutely critical for copper
uptake via hCtr1 but not for localization to the plasma membrane. The aim of the current study was to determine the
importance of these motifs for the copper-responsive endocytosis and degradation of hCtr1 observed previously (6). All histidine residues in the H1 and H2 motifs and methionine residues
in the M1 and M2 motifs were substituted for alanine, and
HEK293 cells were stably transfected with myc-tagged hCtr1
constructs bearing these mutations. After selecting for G418
resistance, surviving populations of cells were screened for
expression of the mutant hCtr1 proteins using immunoblots.
This enabled the identification of cell lines with similar levels
of expression of the monomeric (35-kDa) and multimeric (70kDa) forms of hCtr1 mutant proteins (Fig. 1B).
Immunofluorescence microscopy was used to investigate the
steady-state distribution of each hCtr1 mutant protein in cells
cultured in basal medium and the ability to relocalize in response to elevated copper. The Wt-hCtr1myc protein was located at the plasma membrane in cells cultured in basal medium (Fig. 2A), consistent with previous studies (6). Exposure
of the cells to 100 M copper for 2 h resulted in the relocalization of Wt-hCtr1myc to cytoplasmic vesicles and a clear reduction in fluorescent staining of the cell periphery and overall
signal intensity (Fig. 2B). This result was consistent with the
copper-stimulated endocytosis and degradation of WthCtr1myc protein reported previously (6). Immunofluorescence
analysis of the hCtr1 mutant proteins indicated that for each
mutation there was strong labeling of the periphery of cells
cultured in basal medium conditions, suggesting that none of
the mutations grossly interfered with hCtr1 trafficking to the
plasma membrane (Fig. 2, C, E, G, I, K, M, and O). An incubation for 2 h with 100 M copper stimulated the relocalization of
M1, M2, M1/M2, H1, and H2 mutants to cytoplasmic vesicles
(Fig. 2, D, F, H, J, and L), suggesting that none of these
mutations abolished copper-responsive endocytosis of hCtr1
under these high copper conditions (see below for low copper
conditions). This result was in sharp contrast to the M150A and
M154A mutations, which completely abolished relocalization of
hCtr1 following copper treatment as indicated by the strong

fluorescent staining remaining at the periphery of cells (Fig. 2,
N and P). Longer exposure times and higher concentrations of
copper failed to alter the location of the M150A and M154A
mutant proteins (data not shown). Identical results were obtained when M150 or M154 was replaced with the similarly
sized non-polar residue leucine (data not shown), suggesting
that the defective trafficking response was specific to the loss of
methionine. These findings suggest that the copper-induced
relocalization of hCtr1 is dependent on both methionines
within the conserved 150MXXXM154 sequence.
To examine further the effect of the above mutations on
hCtr1 relocalization, we measured levels of each hCtr1 mutant
protein remaining at the plasma membrane following copper
treatment. The location of the amino-terminal myc tag is extracellular when hCtr1-myc is at the plasma membrane (6, 11,
18). In previous studies we have measured copper-dependent
changes in the pool of hCtr1-myc protein at the plasma membrane by probing non-permeabilized cells with anti-myc antibodies followed by Western blotting to determine the levels of
these antibodies bound to the cell surface (6). Treatment of cells
for 2 h with 100 M copper resulted in a marked reduction in
levels of Wt-hCtr1myc at the plasma membrane (Fig. 3, lanes 3
and 4). In control experiments, there was no binding of antimyc antibodies to the surface of HEK293 cells transfected with
the empty vector (Fig. 3, lanes 1 and 2). Copper treatment also
resulted in a marked reduction in the plasma membrane levels
of H1, H2, M1, M2, and M1/M2 mutant proteins (Fig. 3). However, this surface reduction of H2, M1, and M2 mutants occurred to a lesser extent than that of the wild type protein (see
“Discussion”). Significantly, the surface levels of the M150A
and M154A mutant proteins were not altered by elevated copper concentrations (Fig. 3). This result confirmed our earlier
immunofluorescence data for M150A and M154A mutants,
which indicated that elevated copper did not alter the steadystate distribution of these proteins (Fig. 2).
Because elevated copper also stimulates the degradation of
wild type hCtr1 (6), we tested whether the total abundance of
hCtr1 following exposure to elevated copper levels was affected
by the mutations depicted in Fig. 1. Western blots were used to
detect levels of the hCtr1 mutant proteins in total cell lysates
following a 3-h exposure to 100 M copper in the presence of
cycloheximide to prevent new protein expression (Fig. 4). The
levels of both 35- and 70-kDa forms of the Wt-hCtr1myc protein
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FIG. 3. Analysis of plasma membrane levels of hCtr1 mutant proteins following copper treatment. Immunoblots were used to detect
anti-myc antibodies bound to the surface of HEK293 cells expressing each hCtr1 mutant protein after exposure to either basal medium (⫺) or
medium containing 100 M copper (⫹) for 2 h. Intact cells were cooled on ice and probed with anti-myc antibodies to bind the surface pool of hCtr1.
Total lysates were prepared, and anti-myc antibodies were detected using anti-mouse HRP secondary antibodies. Tubulin protein was detected in
each sample to indicate equal protein loading. mut, mutant.

FIG. 4. Copper-dependent degradation of the hCtr1 mutant
proteins. HEK293 cells expressing each hCtr1 mutant protein were
exposed to either basal medium (⫺) or medium containing 100 M
copper (⫹) for 3 h prior to immunoblot analysis to detect total hCtr1
protein levels using anti-myc antibodies. Tubulin protein levels demonstrate equal protein loading of samples. mut, mutant.

were markedly reduced in response to this copper treatment,
and a similar degree of degradation was observed for the H1
mutant protein (Fig. 4, lanes 13 and 14). Interestingly, the
degradation of the M1, M2, M1/M2, and H2 mutants was
clearly apparent in copper-treated cells; however, in each case
it was not as extensive as for the Wt-hCtr1myc protein (Fig. 4;
see “Discussion”). In contrast, however, the M150A and M154A
mutations completely abolished hCtr1 degradation in response
to copper treatment (Fig. 4, lanes 9 –12). Together with the
immunofluorescence analysis and assays of surface hCtr1 protein levels, these findings suggest that the Met150 and Met154
residues are critical for the copper-stimulated relocalization
and degradation of hCtr1.
A more rigorous analysis of copper-stimulated endocytosis
was undertaken for each of the hCtr1 mutants by assessing the
internalization of anti-myc antibodies added to the culture
medium of cells. We have used this method previously to define
the kinetics, sensitivity, and metal specificity of copper-stimulated endocytosis of hCtr1-myc (6). A low rate of endocytosis of
Wt-hCtr1myc occurred in basal medium, as evident by the
weakly detected internalized anti-myc antibodies (Fig. 5, lane
3). However, endocytosis of Wt-hCtr1myc was stimulated in the
presence of elevated copper as indicated by the increased antibody accumulation (Fig. 5, lane 4). The internalization of antimyc antibodies was dependent on the expression of the hCtr1myc protein because it did not occur in HEK293 cells
expressing the empty pcDNA3.1 vector (Fig. 5, lanes 1 and 2).
For each of the mutants, anti-myc antibodies were internalized
under basal copper conditions, suggesting that none of the
mutations abolished the endocytosis of hCtr1-myc. It was notable that the uptake of anti-myc antibodies from basal medium by the M2 mutant protein was lower than for the wild
type protein (Fig. 5, lane 7). This may be due in part to its lower

FIG. 5. Analysis of copper-dependent endocytosis of the hCtr1
mutant proteins. HEK293 cells stably expressing wild type or mutant
(mut) hCtr1 proteins were allowed to internalize anti-myc antibodies
added to basal medium (⫺) or medium containing 100 M copper (⫹) for
5 min. Surface antibodies were then removed by washing cells in cold
acidic buffer, and intracellular antibodies were then detected by immunoblotting with anti-mouse antibodies conjugated to HRP. Note the
inhibition of copper-stimulated endocytosis of M150A and M154A mutant proteins.

abundance at the plasma membrane (Fig. 3, lane 15), possibly
due to a small reduction in its secretion to the plasma membrane. Elevated copper levels stimulated a marked increase in
the rate of endocytosis for each hCtr1 mutant protein compared
with basal medium, except for the M150A and M154A mutants,
which showed no changes in endocytosis. Increasing the copper
levels above 100 M failed to stimulate endocytosis of the
M150A and M154A mutants above that observed in basal medium (data not shown). These findings, together with earlier
studies, suggested that the Met150 and Met154 residues are
critical not only for copper uptake but also for the copperresponsive endocytosis and degradation of hCtr1.
We have demonstrated previously that the addition of low
micromolar levels of copper to basal medium is sufficient to
stimulate the endocytosis of the hCtr1-myc protein (6). Given
that the M1, M2, H1, and H2 sequences may provide high
affinity copper-binding sites, we investigated whether these
motifs were essential for increasing the rate of hCtr1 endocytosis in response to a range of physiologically relevant copper
concentrations closer to the Km value for hCtr1-mediated copper uptake (⬃2 M copper). As shown in Fig. 6, the endocytosis
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FIG. 6. The sensitivity of amino-terminal hCtr1 mutants to
copper-induced endocytosis. HEK293 cells stably expressing wild
type or mutant (mut) hCtr1 proteins were allowed to internalize antimyc antibodies added to basal medium (0) or medium containing a
range of copper concentrations for 5 min. Surface antibodies were then
removed by washing cells in cold acidic buffer, and intracellular antibodies were then detected by immunoblotting with anti-mouse antibodies conjugated to HRP. Note the higher copper concentrations required
to stimulate endocytosis of the M2 and M1/M2 mutant proteins.

of the Wt-hCtr1myc protein was stimulated by 2 M copper and
saturated between 5 and 20 M copper. A similar dose response
was observed for the endocytosis of M1, H1, and H2 mutants
(Fig. 6). However, the endocytic response of the M2 mutant
protein required copper concentrations greater than 20 M,
suggesting that the sensitivity of this endocytic response was
markedly reduced by this mutation. Moreover, the sensitivity
of the M1/M2 mutant to low copper levels was also reduced and
showed a similar profile to that of the M2 mutant. These
findings suggest that the endocytic response of hCtr1 to low
micromolar copper levels is dependent on the M2 motif and
that the M1 and M2 motifs do not work together in stimulating
hCtr1 endocytosis under these copper conditions.
DISCUSSION

The regulated trafficking of the copper transporters ATP7A,
ATP7B, and hCtr1 is one of the most acutely controlled aspects
of mammalian copper homeostasis (6). The aim of this study
was to test whether the amino-terminal H1, H2, M1, or M2
motifs or the putative intramembraneous 150MXXXM154 motif
of hCtr1 is required for copper-responsive endocytosis. Using a
combinatorial approach, our study has demonstrated that both
methionine residues of the 150MXXXM154 motif are essential
for both copper-stimulated endocytosis and degradation of the
hCtr1 protein. Significantly, previous studies have shown that
this MXXXM motif is also critical for copper uptake via hCtr1,
as well as the yeast orthologue yCtr1 (16). Because the sulfur
ligand of methionine is a soft Lewis base, the MXXXM motif of
the Ctr1 family of proteins has been proposed to constitute a
high affinity binding site for copper(I), a soft Lewis acid, during
its translocation across the membrane channel (16). Our finding that the MXXXM motif is required for copper-stimulated

endocytosis of hCtr1 suggests that copper binding to this motif
during copper transport may also signal endocytosis of the
hCtr1 protein (discussed further below).
Immunocytochemical studies indicated that high copper levels (100 M copper) shifted the steady-state distribution of the
M1, M2, M1/M2, H1, and H2 mutant proteins to a vesicular
distribution, suggesting that none of these mutations completely abolished relocalization of the hCtr1 protein from the
plasma membrane. Consistent with this result was the finding
that the levels of the M1, M2, M1/M2, H1, and H2 mutants at
the plasma membrane were reduced by this same elevated
copper treatment. However, it was notable that the extent of
this reduction in surface levels was lower for the H2, M1, M2,
and M1/M2 mutants compared with the wild type protein.
Similarly, the analysis of total hCtr1 protein levels following
copper treatments suggested that these same mutations reduced the extent of hCtr1 degradation relative to the wild type
protein and probably contributed to the higher surface levels
under these elevated copper conditions. It is currently unclear
why these differences in degradation exist for H2, M1, M2, and
M1/M2 mutants; however, it is possible that mutation of the
M1, M2, and H2 motifs may affect to varying extents hCtr1
endocytosis, intracellular trafficking to degradatory compartments, and/or the degradation process itself.
One of the most significant results of this study was obtained
when we examined the endocytic response of the amino-terminal mutants to low copper concentrations. Although the endocytosis of each amino-terminal mutant protein was responsive
to high copper levels (100 M), the M2 mutation was unique in
preventing the endocytic response to low copper concentrations. These findings suggested that the M2 motif is not critical
for copper-stimulated endocytosis per se but is required for this
process in response to low copper levels within a physiologically
relevant concentration range. It is notable that other studies
have shown a similar requirement for the M2 motif for copper
transport activity under low copper conditions (16). The M2
mutant protein is able to partially complement the copperdeficient phenotype of the yeast ⌬ctr1⌬ctr3⌬ mutant, and unlike the wild type hCtr1 protein it is unable to complement
under copper-depleted conditions (16). Hence, the M2 motif is
required for both high affinity copper transport activity and
copper-stimulated endocytosis when copper levels are low. Together with the 150MXXXM154 mutation described above, the
phenotype of the M2 mutation provides additional evidence
suggesting that both copper transport and trafficking functions
of hCtr1 may be coupled.
How might the copper-responsive endocytosis and transport
functions of hCtr1 be mechanistically coupled? One possibility
is that certain hCtr1 conformations associated with its copper
transport activity may stimulate endocytosis by triggering interactions between an endocytic motif and sorting machinery
on the cytoplasmic face of the plasma membrane. Hence, the
150
MXXXM154 motif mutations may have blocked copper-responsive endocytosis because these mutations abolish transport activity. Because the M2 mutation prevents high affinity
copper transport (16), this may explain why this mutation also
inhibited the endocytic response to low copper concentrations.
The transport-dependent model for hCtr1 endocytosis proposed above has remarkable parallels to that recently proposed
to explain copper-regulated trafficking of the ATP7A and
ATP7B copper ATPases (19). These proteins undergo copperstimulated trafficking from the trans-Golgi network (2, 4), and
like hCtr1, this trafficking response is inhibited by mutations
that block copper transport activity (19 –21). In the case of
ATP7A, the formation of a phosphorylated intermediate as part
of the catalytic cycle of the ATPase is required for copper-
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stimulated trafficking (19). Support for this model comes from
the observation that mutations blocking the formation of this
intermediate also block trafficking and that mutations resulting in the accumulation of this intermediate stimulate trafficking (19). The ATP7A and ATP7B proteins possess a CPC motif
within the sixth transmembrane domain, which, in the case of
ATP7A, is essential for both transport activity and copperresponsive trafficking (20). This CPC motif, which exists as
CPC, CPH, or CPS in other heavy metal ATPases, is thought to
coordinate the metal as it is translocated through the membrane channel. Hence, the requirement for the CPC motif for
both transport and trafficking function is reminiscent of our
findings for the 150MXXXM154 motif of hCtr1, which is also
predicted to reside within a transmembrane region. Other
functional similarities between hCtr1 and the copper ATPases
are apparent when considering the importance of the aminoterminal regions of these proteins. The ATP7A and ATP7B
proteins possess six copper-binding CXXC motifs within their
amino-terminal domains that are critical for copper transport
activity only under low copper levels (22). In the case of ATP7A,
the two motifs closest to the first transmembrane domain are
also required for copper-responsive trafficking (23). In these
respects the CXXC motif of the copper ATPases bears a striking
resemblance to the M2 motif of hCtr1. The significance of these
similarities between the copper ATPases and hCtr1 is unclear;
however, detailed analysis of the transport mechanisms of both
types of copper transporter will likely shed light on how these
proteins mediate the trafficking responses to elevated copper
concentrations. In summary, we have identified the first critical determinants of copper-responsive endocytosis of the hCtr1
copper transporter. Additional biochemical, structural, and cell
biological studies will be required to elucidate the precise steps
involved in mediating both copper uptake and the endocytic
response to elevated copper as well as whether certain copperbound conformations exert regulatory control over both these
processes.
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